TAP1 and ovarian carcinoma: Anka et al. showed that TAP1 was overexpressed in breast, lung, and ovarian cancer, with the frequency of TAP1 alterations in ovarian cancer being the highest among the four types of cancers (Tabassum et al., 2021).